Trial Outcomes & Findings for A User Study of the Soniflow System for Nasal Congestion Relief (NCT NCT04910139)
NCT ID: NCT04910139
Last Updated: 2023-10-12
Results Overview
TNSS is a measure of nasal congestion, measured as the sum of four symptom scores for rhinorrhea, nasal congestion, nasal itching, and sneezing (using a scale of 0=None, 1=Mild, 2=Moderate, or 3=Severe). The minimum TNSS value is 0. The maximum TNSS value is 12. Lower TNSS score means a better outcome
COMPLETED
NA
50 participants
20 minutes
2023-10-12
Participant Flow
Participant milestones
| Measure |
Treatment
Treatment using acoustic energy
Soniflow System: Treatment using acoustic vibrational headband worn circumferentially at the level of the forehead paired with a Smartphone App.
|
|---|---|
|
Overall Study
STARTED
|
50
|
|
Overall Study
COMPLETED
|
50
|
|
Overall Study
NOT COMPLETED
|
0
|
Reasons for withdrawal
Withdrawal data not reported
Baseline Characteristics
A User Study of the Soniflow System for Nasal Congestion Relief
Baseline characteristics by cohort
| Measure |
Treatment
n=50 Participants
Treatment using acoustic energy
Soniflow System: Treatment using acoustic vibrational headband worn circumferentially at the level of the forehead paired with a Smartphone App.
|
|---|---|
|
Age, Categorical
Age · <=18 years
|
0 Participants
n=5 Participants
|
|
Age, Categorical
Age · Between 18 and 65 years
|
46 Participants
n=5 Participants
|
|
Age, Categorical
Age · >=65 years
|
4 Participants
n=5 Participants
|
|
Sex: Female, Male
Female
|
20 Participants
n=5 Participants
|
|
Sex: Female, Male
Male
|
30 Participants
n=5 Participants
|
|
Ethnicity (NIH/OMB)
Hispanic or Latino
|
3 Participants
n=5 Participants
|
|
Ethnicity (NIH/OMB)
Not Hispanic or Latino
|
46 Participants
n=5 Participants
|
|
Ethnicity (NIH/OMB)
Unknown or Not Reported
|
1 Participants
n=5 Participants
|
|
Region of Enrollment
United States
|
50 participants
n=5 Participants
|
|
Total Nasal Symptom Score
|
4.1 units on a scale
n=5 Participants
|
PRIMARY outcome
Timeframe: 20 minutesPopulation: Adult subjects with nasal congestion
TNSS is a measure of nasal congestion, measured as the sum of four symptom scores for rhinorrhea, nasal congestion, nasal itching, and sneezing (using a scale of 0=None, 1=Mild, 2=Moderate, or 3=Severe). The minimum TNSS value is 0. The maximum TNSS value is 12. Lower TNSS score means a better outcome
Outcome measures
| Measure |
Treatment
n=50 Participants
Treatment using acoustic energy
Soniflow System: Treatment using acoustic vibrational headband worn circumferentially at the level of the forehead paired with a Smartphone App.
|
|---|---|
|
Total Nasal Symptom Score
|
2.0 score on a scale
Interval 1.6 to 2.5
|
SECONDARY outcome
Timeframe: 20 minutesPopulation: adults with nasal congestion
Visual Analog Scale (VAS) for Headache, using a scale of 0-10. 0 is the minimum and 10 is maximum on this scale. Lower scores mean a better outcome.
Outcome measures
| Measure |
Treatment
n=50 Participants
Treatment using acoustic energy
Soniflow System: Treatment using acoustic vibrational headband worn circumferentially at the level of the forehead paired with a Smartphone App.
|
|---|---|
|
Visual Analog Scale (VAS) for Headache
|
0.9 score on a scale of 0-10
Interval 0.4 to 1.5
|
SECONDARY outcome
Timeframe: 20 minutesPopulation: adults with nasal congestion
Visual Analog Scale (VAS) for Facial Pain, using a scale of 0-10. 0 is minimum and 10 is the maximum value for this scale. Lower scores mean a better outcome.
Outcome measures
| Measure |
Treatment
n=50 Participants
Treatment using acoustic energy
Soniflow System: Treatment using acoustic vibrational headband worn circumferentially at the level of the forehead paired with a Smartphone App.
|
|---|---|
|
Visual Analog Scale (VAS) for Facial Pain
|
0.9 score on a scale (of 0-10)
Interval 0.5 to 1.5
|
Adverse Events
Treatment
Serious adverse events
Adverse event data not reported
Other adverse events
Adverse event data not reported
Additional Information
Results disclosure agreements
- Principal investigator is a sponsor employee
- Publication restrictions are in place